Proteome Sciences plc

AIM:PRM Rapport sur les actions

Capitalisation boursière : UK£8.0m

Proteome Sciences Résultats passés

Passé contrôle des critères 0/6

Proteome Sciences's earnings have been declining at an average annual rate of -49.1%, while the Life Sciences industry saw earnings growing at 13.9% annually. Revenues have been growing at an average rate of 7.7% per year.

Informations clés

-49.1%

Taux de croissance des bénéfices

-49.1%

Taux de croissance du BPA

Life Sciences Croissance de l'industrie36.9%
Taux de croissance des recettes7.7%
Rendement des fonds propresn/a
Marge nette-101.1%
Dernière mise à jour des bénéfices30 Jun 2024

Mises à jour récentes des performances passées

Recent updates

Here's Why Shareholders Should Examine Proteome Sciences plc's (LON:PRM) CEO Compensation Package More Closely

May 10
Here's Why Shareholders Should Examine Proteome Sciences plc's (LON:PRM) CEO Compensation Package More Closely

Here's Why We Think Proteome Sciences (LON:PRM) Is Well Worth Watching

Dec 02
Here's Why We Think Proteome Sciences (LON:PRM) Is Well Worth Watching

Here's Why Proteome Sciences (LON:PRM) Has Caught The Eye Of Investors

Aug 25
Here's Why Proteome Sciences (LON:PRM) Has Caught The Eye Of Investors

Here's Why Proteome Sciences (LON:PRM) Has Caught The Eye Of Investors

Dec 22
Here's Why Proteome Sciences (LON:PRM) Has Caught The Eye Of Investors

Do Proteome Sciences' (LON:PRM) Earnings Warrant Your Attention?

Sep 03
Do Proteome Sciences' (LON:PRM) Earnings Warrant Your Attention?

Calculating The Fair Value Of Proteome Sciences plc (LON:PRM)

Jan 27
Calculating The Fair Value Of Proteome Sciences plc (LON:PRM)

Does Proteome Sciences (LON:PRM) Deserve A Spot On Your Watchlist?

May 31
Does Proteome Sciences (LON:PRM) Deserve A Spot On Your Watchlist?

Some Confidence Is Lacking In Proteome Sciences plc's (LON:PRM) P/E

Apr 04
Some Confidence Is Lacking In Proteome Sciences plc's (LON:PRM) P/E

Ventilation des recettes et des dépenses

Comment Proteome Sciences gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.


Historique des gains et des recettes

AIM:PRM Recettes, dépenses et bénéfices (GBP Millions )
DateRecettesLes revenusDépenses G+ADépenses de R&D
30 Jun 244-430
31 Mar 245-330
31 Dec 235-230
30 Sep 236-130
30 Jun 238130
31 Mar 238130
31 Dec 228130
30 Sep 227120
30 Jun 226120
31 Mar 226020
31 Dec 215020
30 Sep 215020
30 Jun 215020
31 Mar 215020
31 Dec 205020
30 Sep 205020
30 Jun 205030
31 Mar 205030
31 Dec 195030
30 Sep 194030
30 Jun 193020
31 Mar 193-130
31 Dec 183-130
30 Sep 183-230
30 Jun 183-240
31 Mar 183-240
31 Dec 173-240
30 Sep 173-240
30 Jun 173-240
31 Mar 173-240
31 Dec 163-240
30 Sep 162-340
30 Jun 162-340
31 Mar 162-340
31 Dec 152-340
30 Sep 152-340
30 Jun 152-350
31 Mar 152-350
31 Dec 142-450
30 Sep 142-341
30 Jun 142-332
31 Mar 142-332
31 Dec 132-332

Des revenus de qualité: PRM is currently unprofitable.

Augmentation de la marge bénéficiaire: PRM is currently unprofitable.


Analyse des flux de trésorerie disponibles par rapport aux bénéfices


Analyse de la croissance passée des bénéfices

Tendance des revenus: PRM is unprofitable, and losses have increased over the past 5 years at a rate of 49.1% per year.

Accélération de la croissance: Unable to compare PRM's earnings growth over the past year to its 5-year average as it is currently unprofitable

Bénéfices par rapport au secteur d'activité: PRM is unprofitable, making it difficult to compare its past year earnings growth to the Life Sciences industry (-0.7%).


Rendement des fonds propres

ROE élevé: PRM's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Rendement des actifs


Rendement des capitaux employés


Découvrir des entreprises performantes dans le passé